These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32187671)

  • 1. Author response to: Comment on: External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Ipenburg NA; Nieweg OE; Lo S
    Br J Surg; 2020 Apr; 107(5):616. PubMed ID: 32187671
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Verver D; Rekkas A; Grünhagen DJ; Verhoef C
    Br J Surg; 2020 Apr; 107(5):615-616. PubMed ID: 32187674
    [No Abstract]   [Full Text] [Related]  

  • 3. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Ipenburg NA; Nieweg OE; Ahmed T; van Doorn R; Scolyer RA; Long GV; Thompson JF; Lo S
    Br J Surg; 2019 Sep; 106(10):1319-1326. PubMed ID: 31310333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single-Institution Experience and Literature Meta-Analysis.
    L B; S S; G G; P B; C C; R G; V G; E C
    J Invest Surg; 2019 Mar; 32(2):151-161. PubMed ID: 29058494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
    Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
    Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
    Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
    Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
    Hao H; Xiao D; Pan J; Qu J; Egger M; Waigel S; Sanders MA; Zacharias W; Rai SN; McMasters KM
    Ann Surg Oncol; 2017 Jan; 24(1):108-116. PubMed ID: 27663566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma.
    Zagarella S; Lee S; Heenan P
    Australas J Dermatol; 2017 Nov; 58(4):256-258. PubMed ID: 29064087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
    Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
    Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
    Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
    Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Disease in Sentinel-negative Melanoma Patients: Biological Differences and Importance of Sentinel Lymph Node Biopsy.
    Conrad A; Reinehr M; Holzmann D; Mangana J; Wanner M; Huellner M; Barnhill RL; Lugassy C; Lindenblatt N; Mihic-Probst D
    Anticancer Res; 2020 Feb; 40(2):891-899. PubMed ID: 32014933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative Melanoma.
    Erdmann M; Sigler D; Uslu U; Göhl J; Grützmann R; Schuler G; Schellerer V
    Anticancer Res; 2018 Nov; 38(11):6571-6577. PubMed ID: 30396988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.
    Thomas DC; Han G; Leong SP; Kashani-Sabet M; Vetto J; Pockaj B; White RL; Faries MB; Schneebaum S; Mozzillo N; Charney KJ; Sondak VK; Messina JL; Zager JS; Han D
    Ann Surg Oncol; 2019 Jul; 26(7):2254-2262. PubMed ID: 31011906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node in Melanoma -  a Study Conducted in the South of Brazil.
    Rovere RK; A Sde L; Demarchi V; Stein CE
    Klin Onkol; 2016; 29(4):274-8. PubMed ID: 27534784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
    Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
    Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.